Grantham, Mayo, Van Otterloo & Co (GMO)’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,300	Closed	-$129K	–	817
2020 Q1	$129K	Sell	18,300 -1,700	-9%	-$12K	﹤0.01%	719
2019 Q4	$141K	Sell	20,000 -18,400	-48%	-$130K	﹤0.01%	658
2019 Q3	$461K	Buy	+38,400	New	+$461K	﹤0.01%	637